Sign In
Buy RMD
$188.63
+2.34 (+1.26%)
At Close: Jun 18, 2026
This ResMed Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
09:13am, Wednesday, 17'th Jun 2026
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings pag
Futures are trading mixed as we hit the midweek point, as the Space Exploration Technologies (NASDAQ: SPCX) or SpaceX IPO rush is starting to fade somewhat.
Why ResMed (RMD) is a Top Growth Stock for the Long-Term
10:46am, Tuesday, 16'th Jun 2026
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
ResMed: GLP-1 Threats Are Overstated
07:05am, Thursday, 11'th Jun 2026
My contrarian take on ResMed is that GLP-1 concerns are overstated, and even though a portion of market share will be lost, the remaining portion will be more beneficial to profitability. Other busine
Is This the Right Time to Retain Resmed Stock in Your Portfolio?
09:55am, Tuesday, 09'th Jun 2026
RMD gains from acquisition-led Residential Care Software growth, mask innovation and strong finances but faces macro and competitive pressures.
Top 50 High-Quality Dividend Growth Stocks For June 2026
04:51am, Monday, 08'th Jun 2026
I track a curated universe of 50 high-quality dividend growth stocks to identify attractive entry points based on valuation and forward return potential. Year-to-date, the universe lags SPY and SCHD,
A Look at ResMed Inc (RMD) After 4.2% Gain -- GF Value $271.26 vs Price $194.32
05:57pm, Thursday, 04'th Jun 2026
On June 04, 2026, ResMed Inc (RMD) shares rose 4.2% today, currently trading at $194.32. The stock has seen a 52-week range between $180.27 and $293.81, highlig
Angelini Ventures Marks First Portfolio Company Exit as ResMed Acquires Noctrix Health for $340 million
07:40am, Wednesday, 03'rd Jun 2026
Angelini Ventures marks its first portfolio exit as ResMed acquires Noctrix Health, validating its strategy of backing breakthrough healthcare innovation.
ResMed Inc. (RMD) Presents at 46th Annual William Blair Growth Stock Conference Prepared Remarks Transcript
04:04am, Wednesday, 03'rd Jun 2026
ResMed Inc. (RMD) Presents at 46th Annual William Blair Growth Stock Conference Prepared Remarks Transcript
Resmed Completes Acquisition of Noctrix Health, Expanding Clinical Sleep Health Portfolio
04:05pm, Monday, 01'st Jun 2026
Acquisition adds Nidra® Tonic Motor Activation (TOMAC) Therapy, an FDA De Novo classified, nonpharmacologic treatment designed to address moderate-to-severe Restless Legs Syndrome (RLS). Acquisition
ResMed (RMD) is a Top-Ranked Growth Stock: Should You Buy?
10:46am, Tuesday, 26'th May 2026
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
The Hidden 401(k) Tax Bomb That Hits a $1.3 Million Saver With $19,800 in Their First RMD Year
11:21pm, Sunday, 24'th May 2026
Picture a single 73-year-old retiree sitting on $1.3 million in a traditional 401(k), drawing $36,000 a year in Social Security, and feeling reasonably set for retirement.
The In Plan Roth 401(k) Conversion That Saves a $400,000 Earner $58,000 in Future RMD Taxes
01:47pm, Friday, 22'nd May 2026
Picture a 55-year-old earning $400,000 with $1.5 million in a traditional 401(k).
Is the Options Market Predicting a Spike in ResMed Stock?
03:40pm, Wednesday, 20'th May 2026
Investors need to pay close attention to RMD stock based on the movements in the options market lately.
Resmed Announces Participation in the 46th Annual William Blair Growth Stock Conference
04:05pm, Tuesday, 19'th May 2026
SAN DIEGO, May 19, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chairman and chief executive officer, and Aaron Bloomer, chief financial officer, will attend the
